BackAcorda Therapeutics Overview

Acorda Therapeutics Current Assets

Track Acorda Therapeutics's current assets ($48M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$48.45M
28.84% YoYΔ $-19.64M vs prior year quarter

Peer average

Loading

Acorda Therapeutics Current Assets History

Loading

Acorda Therapeutics vs. peers: Current Assets Comparison

Loading

Acorda Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acorda Therapeutics (ACOR) FAQ

As of the most recent data (March 2024), ACOR shows a current assets of $48M. That compares with $68M in the prior-year period — down 28.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACOR's current assets is now $48M (was $68M) — a 28.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Acorda Therapeutics is outperforming or lagging.

Tracking ACOR's current assets over time shows whether Acorda Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $48M That compares with $68M in the prior-year period — down 28.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Acorda Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $48M) with ownership activity and broader fundamentals.

Acorda Therapeutics's current assets is $48M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.